A study protocol of a randomized trial evaluating the effect of using defined menu plans within an intensive personal nutritional counseling program on cardiovascular risk factors: The MoKaRi (modulation of cardiovascular risk factors) trial

Christine Dawczynski, Paul M Cullen, Peter Schlattmann, Stefan Lorkowski, Christine Dawczynski, Paul M Cullen, Peter Schlattmann, Stefan Lorkowski

Abstract

Importance: Changes in dietary habits and lifestyle can reduce the risk of cardiovascular disease which is the leading cause of death worldwide. Objectives of the MoKaRi study The MoKaRi (modulation of cardiovascular risk factors) intervention study is designed to evaluate the effectiveness and potential of the developed MoKaRi concept. The MoKaRi concept comprises three components, each designed to improve dietary behavior. The first component entails using daily menu plans to implement a defined "cardioprotective diet". This diet consists of seasonal menu plans which are characterized by:(i) a personalized energy supply depending on his or her age, gender, level of physical activity.(ii) an adequate intake of carbohydrates, protein, fat, vitamins, minerals, and trace elements according to the guidelines of the German Society of Nutrition (DGE).(iii) a recommended intake of saturated fatty acids (SFA; < 7% of caloric intake (En%)), monounsaturated fatty acids (MUFA; > 10 En%), polyunsaturated fatty acids.(PUFA; approx. 10 En%), and long-chain n-3 PUFA (≥500 mg per day).(iv) measures to encourage consumption of vegetables and fruits, and.(v) eating more than 40 g dietary fiber every day.Half of the participants will be scheduled to consume an additional 3 g of long-chain n- 3 PUFA every day in the form of fish oil.The second component consists of regular one-on-one nutritional counseling, while a variety of further incentives make up the third component of the MoKaRi concept.The MoKaRi study will provide essential insights into the relationship between defined nutrient intake, markers of food intake and health status. Our specific aim is to investigate the influence of dietary and lifestyle choices have on cardiovascular health.The information and practical tools suitable for daily use, such as the personalized menu plans, could help to transfer knowledge on nutritional facts to the general population. In this way, the validated MoKaRi concept may contribute to the prevention and therapy of cardiovascular diseases.

Methods: In line with our power calculation, we will enroll 60 participants and randomly assign them to one of two parallel arms. Each participant will receive personalized menu plans for each day of the study and will be provided with one-on-one nutritional counseling sessions every two weeks for a study period of 20 weeks (140 days). During this period, blood samples will be taken every 14 days (11 time points) and twice during a 20-weeks follow-up period. Incentives such as a supply of foods approved according t the standards of the study, a sports program, individual feedback on study parameters reflecting health status, and group activities round off the MoKaRi concept.Low-density cholesterol is the primary outcome measure of the MoKaRi study, and the secondary endpoints comprise markers of nutrient status (e.g. fatty acid distribution in plasma and erythrocyte lipids), a metabolomic profiling, diabetes risk markers, clotting markers, and further cardiovascular risk factors, such as blood lipids, homocysteine and high-sensitive c-reactive protein.The MoKaRi study was registered before launch at ClinicalTrials.gov (identifier NCT02637778; https://ichgcp.net/clinical-trials-registry/NCT02637778).

Keywords: Cardiovascular risk factors; Defined nutrient intake; Dietary fat; Dietary fibers; Nutritional counseling.

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Lorkowski reports personal fees from Akcea Therapeutics, amedes, AMGEN, Berlin-Chemie, Boehringer Ingelheim Pharma, Danone, Daiichi Sankyo, Lilly, MSD Sharp & Dohme, Novo Nordisk Pharma, Roche Pharma, Sanofi-Aventis, Swedish Orphan Biovitrum, Synlab, Unilever, and Upfield, and non-financial support from Preventicus outside the submitted work.

© 2021 The Authors. Published by Elsevier Inc.

Figures

Fig. 1
Fig. 1
Study design of the MoKaRi trial.
Fig. 2
Fig. 2
The MoKaRi concept.
Fig. 3
Fig. 3
Example of a menu plan according to the MoKaRi concept. The above daily menu plan is adapted to fit the requirements of a woman aged between 51 ≤ 65 yrs with a PAL of 1.6 which corresponds to a daily energy intake of 2000 kcal.
Fig. 3
Fig. 3
Example of a menu plan according to the MoKaRi concept. The above daily menu plan is adapted to fit the requirements of a woman aged between 51 ≤ 65 yrs with a PAL of 1.6 which corresponds to a daily energy intake of 2000 kcal.
Fig. 4
Fig. 4
Screenshots of the smartphone app to track risk factors.

References

    1. GBD 2017 Causes of Death Collaborators, Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. doi: 10.1016/S0140-6736(18)32203-7.
    1. Mendis S., Puska P., Norrving B., World Health Organization . Shanthi Mendis et al. World Health Organization; 2011. Global Atlas on Cardiovascular Disease Prevention and Control/ World Heart Federation et al. accessed.
    1. Alberico L.C., Graham I., De Backer G., Wiklund O., Chapman M.J., Drexel H., Hoes A.W., Jennings C.S., Landmesser U., Pedersen T.R., Reiner Ž., Riccardi G., Taskinen M.R., Tokgozoglu L., Verschuren W.M.M., Vlachopoulos C., Wood D.A., Zamorano J.L., Cooney M.T. ESC scientific document group 2016, ESC/EAS guidelines for the management of dyslipidaemias. Eur. Heart J. 2016;37:2999–3058. doi: 10.1016/j.rec.2017.01.002.
    1. DeSalvo K.B., Olson R., Casavale K.O. Dietary Guidelines Am. JAMA. 2016;315:457–458.
    1. GBD 2017 diet collaborators, health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;393:1958–1972. doi: 10.1016/S0140-6736(19)30041-8.
    1. Smith S.C., Jackson R., Pearson T.A., Fuster V., Yusuf S., Faergeman O., Wood D.A., Alderman M., Horgan J., Home P., Hunn M., Grundy S.M. Principles for national and regional guidelines on cardiovascular disease prevention. A scientific statement from the World Heart and Stroke Forum. Circulation. 2004;109:3112–3121. doi: 10.1161/01.CIR.0000133427.35111.67.
    1. Cordain L., Eaton S.B., Sebastian A., Mann N., Lindeberg S., Watkins B.A., O'Keefe J.H., Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am. J. Clin. Nutr. 2005;81:341–354. doi: 10.1093/ajcn.81.2.341.
    1. MRI Nationale Verzehrsstudie II. Max-Rubner-Institut Bundesforschungsinstitut für Ernährung und Lebensmittel. 2008. accessed.
    1. D-A-CH . aktualisierte Ausgabe; Bonn: 2018. Referenzwerte für die Nährstoffzufuhr der DGE, ÖGE, SGE/SVE, 2. Auflage, 4.
    1. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Scientific Opinion on the substantiation of health claims related to EPA, DHA, DPA and maintenance of normal blood pressure (ID 502), maintenance of normal HDL-cholesterol concentrations (ID 515), maintenance of normal (fasting) blood concentrations of triglycerides (ID 517), maintenance of normal LDL-cholesterol concentrations (ID 528, 698) and maintenance of joints (ID 503, 505, 507, 511, 518, 524, 526, 535, 537) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2009;7:1263. doi: 10.2903/j.efsa.2009.1263.
    1. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523), contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and “immunomodulating agent” (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2010;8:1796. doi: 10.2903/j.efsa.2010.1796.
    1. Dawczynski C., Dittrich M., Neumann T., Goetze K., Oelzner P., Völker S., Schaible A.M., Troisi F., Thomas L., Pace S., Koeberle A., Werz O., Schlattmann P., Lorkoswki S., Jahreis G. Docosahexaenoic acid in the treatment of rheumatoid arthritis: a double-Blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil. Clin. Nutr. 2018;37:494–504. doi: 10.1016/j.clnu.2017.02.021.
    1. Lim S.S., Vos T., Flaxman A.D. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260. doi: 10.1016/S0140-6736(12)61766-8.
    1. Heron M. Deaths: leading causes for 2017. Natl. Vital Stat. Rep. 2019;68:6.
    1. Rees K., Dyakova M., Ward K., Thorogood M., Brunner E. Dietary advice for reducing cardiovascular risk. Cochrane Database Syst. Rev. 2013;3 doi: 10.1002/14651858.CD002128.pub3. CD002128.
    1. International Society for the Study of Fatty Acids and Lipids (ISSFAL). Report of the Sub-committee on: Recommendations for Intake of Polyunsaturated Fatty Acids in Healthy Adults. ISSFAL; Brighton: 2004.
    1. Bandura A. W H Freeman/Times Books/Henry Holt & Co; 1997. Self-efficacy: the Exercise of Control.
    1. Al-Qaisi M., Nott D.M., King D.H., Kaddoura S. Ankle brachial pressure index (ABPI): an update for practitioners. Vasc. Health Risk Manag. 2009;5:833–841. doi: 10.2147/VHRM.S6759.
    1. Jenkins D.J., Kendall C.W., Faulkner D., Vidgen E., Trautwein E.A., Parker T.L., Marchie A., Koumbridis G., Lapsley K.G., Josse R.G., Leiter L.A., Connelly P.W. A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism. 2002;51:1596–1604. doi: 10.1053/meta.2002.35578.
    1. World Medical Association Declaration of Helsinki: ethical principles for medical Research involving human subjects. J. Am. Med. Assoc. 2013;310:2191–2194.
    1. Cherry K. The incentive theory of motivation - are actions B a desire for rewards? 2018. Updated November 20. 2 March 2019.

Source: PubMed

Подписаться